Therefore, in order to determine the pathophysiological relevance of AP-1 down-modulation in human cardiac cells, we next analyzed the expression of various genes that had been reportedly demonstrated to be targeted by the AP-1 transcription factor and also be involved in cardiac disease. This evidence concerns the gene FOS and heart disorder.